European Archives - Page 667 of 1176 - European Medical Journal

Latest Developments in Liver Health Diagnosis and Management

Update your knowledge on NAFLD and its metabolic comorbidities, learn about real-world aspects of NAFLD and its treatment, as well as about the…

Start-ups and Entrepreneurship

Jeremy Stone, Healthcare Entrepreneur, Innovator, and Physician, talks about the importance of entrepreneurship and investing in start-ups.

Could MVT-602 Be a Novel Fertility-Improving Drug?

Fertility in women with reproductive health problems can be improved using a new drug according to a recent study. Find out more

Female Reproductive Steroids May Protect Against COVID-19 Symptoms

Prof Graziano Pinna, University of Illinois, found an indication that female reproductive steroids may play a protective role against Covid-19

Gene Signature Predicts Prostate Cancer Metastasis Risk

PREDICTING probability of metastasis in prostate cancer may be more reliable, thanks to a new gene signature identified by researchers from the…

Smart Device Designed for Underactive Bladders

IMPLANTABLE smart devices have been designed to potentially provide assistance in the management of underactive bladders. A study by researchers…

What more can you do to help your pediatric patients with recurrent viral wheezing?

The aim of this webinar is to share highlights on the topic “ Management of recurrent pediatric respiratory infections and complications: a missed…

TDM and T2T- Perfect Partners

This webinar explores the longstanding relationship between therapeutic drug monitoring (TDM) and inflammatory bowel disease (IBD)

EMJ Podcast: Dynamic Management of CD: Reaching a New Dimension in Patient Care

This episode will provide an overview of the UEG Week Virtual 2020 symposium ‘Dynamic management of CD: reaching a new dimension in patient care’, which highlights the latest developments in Crohn’s disease management.

The future of orphan drugs

In this infographic, we showcase the top performing orphan drug predictions for 2024 and identify the companies leading the way in this space. We also consider the six key steps for orphan drug launch success.